Wealthfront Advisers LLC purchased a new stake in shares of Ventas, Inc. (NYSE:VTR – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 107,765 shares of the real estate investment trust’s stock, valued at approximately $9,570,000.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Meeder Advisory Services Inc. purchased a new position in Ventas during the 2nd quarter worth approximately $491,000. Meeder Asset Management Inc. acquired a new stake in shares of Ventas in the second quarter worth $30,000. Banco BTG Pactual S.A. purchased a new position in shares of Ventas during the second quarter valued at $548,000. NINE MASTS CAPITAL Ltd acquired a new position in Ventas during the second quarter valued at $222,000. Finally, BlackRock Inc. purchased a new stake in Ventas in the 2nd quarter worth about $4,953,439,000. Institutional investors and hedge funds own 94.18% of the company’s stock.
Ventas Stock Up 0.7%
Shares of Ventas stock opened at $91.81 on Thursday. The stock has a market capitalization of $47.09 billion, a P/E ratio of 170.02, a PEG ratio of 2.10 and a beta of 0.69. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock has a 50 day moving average price of $91.00 and a two-hundred day moving average price of $86.93. Ventas, Inc. has a 12-month low of $66.38 and a 12-month high of $101.60.
Insider Activity
In other news, Director Michael J. Embler bought 2,500 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This represents a 14.97% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.53% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on VTR shares. Royal Bank Of Canada lifted their target price on Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research note on Friday, August 14th. Wells Fargo & Company lifted their target price on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Barclays started coverage on shares of Ventas in a report on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price target on the stock. JPMorgan Chase & Co. increased their price objective on Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Finally, Citigroup increased their price objective on Ventas from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Tuesday, August 4th. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $98.00.
View Our Latest Analysis on Ventas
Ventas Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Further Reading
- Five stocks we like better than Ventas
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
